Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Hélène Massinet"'
Autor:
Nicolas Brezillon, Marie-Noëlle Brunelle, Hélène Massinet, Eric Giang, Céline Lamant, Lucie DaSilva, Sophie Berissi, Jacques Belghiti, Laurent Hannoun, Gherard Puerstinger, Eva Wimmer, Johan Neyts, Olivier Hantz, Patrick Soussan, Serban Morosan, Dina Kremsdorf
Publikováno v:
PLoS ONE, Vol 6, Iss 12, p e25096 (2011)
Current treatments for HBV chronic carriers using interferon alpha or nucleoside analogues are not effective in all patients and may induce the emergence of HBV resistant strains. Bay 41-4109, a member of the heteroaryldihydropyrimidine family, inhib
Externí odkaz:
https://doaj.org/article/ce3067c018d44286925e45fb1cf480f7
Autor:
Giorgio Bergamini, Helene Massinet, Aaron Hart, Sean Durkin, Gabin Pierlot, Michel Alexander Steiner
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
IntroductionPeople with dementia (PwD) often present with neuropsychiatric symptoms (NPS). NPS are of substantial burden to the patients, and current treatment options are unsatisfactory. Investigators searching for novel medications need animal mode
Externí odkaz:
https://doaj.org/article/21b82098baf14fe093e698de1f45b18a
Publikováno v:
Frontiers in Psychiatry, Vol 13 (2022)
Neuropsychiatric symptoms (NPS) affect people with dementia (PwD) almost universally across all stages of the disease, and regardless of its exact etiology. NPS lead to disability and reduced quality of life of PwD and their caregivers. NPS include h
Externí odkaz:
https://doaj.org/article/3b5ca233273d474eabc8bfab30253516
Autor:
Eric Giang, Jacques Belghiti, Serban Morosan, Sophie Berissi, Céline Lamant, Johan Neyts, Eva Wimmer, Gherard Puerstinger, Patrick Soussan, Lucie DaSilva, Olivier Hantz, Marie-Noëlle Brunelle, Laurent Hannoun, Dina Kremsdorf, Hélène Massinet, Nicolas Brezillon
Publikováno v:
PLoS ONE
PLoS ONE, Public Library of Science, 2011, 6 (12), pp.e25096. ⟨10.1371/journal.pone.0025096⟩
PLoS ONE, Public Library of Science, 2011, 6 (12), pp.e25096. 〈10.1371/journal.pone.0025096〉
PLoS ONE, Vol 6, Iss 12, p e25096 (2011)
PLoS ONE, Public Library of Science, 2011, 6 (12), pp.e25096. ⟨10.1371/journal.pone.0025096⟩
PLoS ONE, Public Library of Science, 2011, 6 (12), pp.e25096. 〈10.1371/journal.pone.0025096〉
PLoS ONE, Vol 6, Iss 12, p e25096 (2011)
International audience; Current treatments for HBV chronic carriers using interferon alpha or nucleoside analogues are not effective in all patients and may induce the emergence of HBV resistant strains. Bay 41-4109, a member of the heteroaryldihydro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a0dd9cf1b174f9e3a9618191926e7bb
https://hal.archives-ouvertes.fr/hal-00782108
https://hal.archives-ouvertes.fr/hal-00782108
Autor:
Didier Saboulard, Céline Lamant, Hélène Massinet, Nicolas Brezillon, Marie Noëlle Brunelle, Dina Kremsdorf, Patrick Soussan
Publikováno v:
Antiviral therapy. 15(6)
Background Treatment of HBV chronic carriers using interferon (IFN)-α or nucleoside/nucleotide analogues fails to suppress viral infection. Type-II IFN-γ has been shown to inhibit HBV replication. The goal of the present work was to evaluate the an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4410c3790d55831cf80922c929b475f0
https://pubmed.ncbi.nlm.nih.gov/20834098
https://pubmed.ncbi.nlm.nih.gov/20834098
Autor:
Patrick Soussan, Hélène Massinet, S. Berissi, Nicolas Brezillon, Dina Kremsdorf, Ivan Quetier
Publikováno v:
Journal of Hepatology. 56:S179
Results: Endogenous expression of L-, S-, coreor HBe-protein did not result in a significant interference with the subsequent infection with HDV. However, expression of L-protein drastically reduced HBV infection efficacy. In contrast, S-protein expr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0b9591b7af187b0a717083a43874e33
https://doi.org/10.1016/s0168-8278(12)60465-6
https://doi.org/10.1016/s0168-8278(12)60465-6